Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | KIF11 | P52732 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.39 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.39 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5758 | 0.97 | TSHR (0.55) | TSHRLMNATYRCYP2A6HDAC1 | |
| Methane SCHEMBL27627147 | 0.94 | TSHR (0.52) | TSHRLMNATYRCYP2A6HDAC1 | |
| Water SCHEMBL28307832 | 0.94 | TSHR (0.52) | TSHRLMNATYRCYP2A6HDAC1 | |
| Methoxymethane SCHEMBL28225538 | 0.89 | TSHR (0.48) | TSHRLMNATYRCYP2A6HDAC1 | |
| SCHEMBL12367606 | 0.89 | KIF11 (0.56) | TSHRLMNATYRCYP2A6HDAC1 | |
| SCHEMBL177404 | 0.89 | KIF11 (0.56) | TSHRLMNATYRCYP2A6HDAC1 | |
| Bromobenzene SCHEMBL9230161 | 0.87 | ALDH1A1 (0.55) | TSHRLMNATYRCYP2A6HDAC1 | |
| SCHEMBL21340595 | 0.85 | KIF11 (0.46) | TSHRLMNATYRCYP2A6HDAC1 | |
| SCHEMBL1979907 | 0.83 | CYP1A2 (0.53) | TSHRLMNATYRHDAC1ALDH1A1 | |
| SCHEMBL9458566 | 0.83 | MAOA (0.47) | TSHRLMNATYRHDAC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119859156-A | Boron-nitrogen organic compound, preparation method and application thereof, composition and photoelectric device | 广东聚华印刷显示技术有限公司 | 2025-04-22 | — | — | CN | claimed |
| CN-119462532-A | Near infrared material suitable for solution processing and preparation method and application thereof | 广东工业大学 | 2025-02-18 | — | — | CN | claimed |
| CN-118908996-A | A composition containing C (sp2) P bond or C (sp)3) Process for preparing organic phosphine compound of-P bond | 烟台大学 | 2024-11-08 | — | — | CN | claimed |
| CN-120757479-A | Preparation method of 4-tert-butylphenyl-diphenyl sulfonium p-toluenesulfonate | 河北圣泰材料股份有限公司 | 2025-10-10 | — | — | CN | disclosed |
| CN-116410088-B | Synthesis method of alpha-aryl propionate compound | 南京工业大学 | 2025-05-02 | — | — | CN | disclosed |
| CN-119859156-A | Boron-nitrogen organic compound, preparation method and application thereof, composition and photoelectric device | 广东聚华印刷显示技术有限公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-119798292-A | Polycyclic fusion molecule containing oxygen, boron and nitrogen coordination bonds and preparation method thereof | 华侨大学 | 2025-04-11 | — | — | CN | disclosed |
| CN-119462532-A | Near infrared material suitable for solution processing and preparation method and application thereof | 广东工业大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-115362153-B | Azaspiro compounds as monoacylglycerol lipase modulators | 詹森药业有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-118908996-A | A composition containing C (sp2) P bond or C (sp)3) Process for preparing organic phosphine compound of-P bond | 烟台大学 | 2024-11-08 | — | — | CN | disclosed |
| CN-113896607-B | Olefin oligomerization process using a catalyst comprising a chromium complex having a phosphacycle-containing ligand | 陶氏环球技术有限责任公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20060009597-A1 | Catalysts for olefin polymerization or oligomerization | DUPONT POLYMERS, INC. | 2006-01-12 | — | — | US | disclosed |
| EP-1192165-B1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2004-09-22 | — | — | EP | disclosed |
| US-6713471-B1 | SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-30 | — | — | US | disclosed |
| US-20030232891-A1 | Substituted C-cyclohexylmethylamine derivatives | GRUENENTHAL GMBH (DE) | 2003-12-18 | — | — | US | disclosed |
| EP-1192165-A2 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | Bristol-Myers Squibb Pharma Company (US) | 2002-04-03 | — | — | EP | disclosed |
| WO-2000077010-A2 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-12-21 | — | — | WO | disclosed |
| EP-0259972-B1 | HETEROCYCLIC PROPENE AMIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | LILLY INDUSTRIES LIMITED (GB) | 1993-07-14 | — | — | EP | disclosed |
| US-4983619-A | Leukotriene antagonists | LILLY INDUSTRIES LIMITED (GB) | 1991-01-08 | — | — | US | disclosed |
| EP-0259972-A2 | Heterocyclic propene amide derivatives, processes for their preparation and their use as pharmaceuticals | LILLY INDUSTRIES LIMITED (GB) | 1988-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060009597-A1 | Catalysts for olefin polymerization or oligomerization | PPOX, HMOX1, NOD2 | TSHR 3796/4885LMNA 3782/4885TYR 1391/4885 |
| US-20030232891-A1 | Substituted C-cyclohexylmethylamine derivatives | CNR2, CNR1, HNMT | TSHR 3507/4885LMNA 1553/4885TYR 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.